161 related articles for article (PubMed ID: 24925528)
1. Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer.
Zhang Y; Huang H; Zhou H; Du T; Zeng L; Cao Y; Chen J; Lai Y; Li J; Wang G; Guo Z
Cancer; 2014 Oct; 120(20):3208-18. PubMed ID: 24925528
[TBL] [Abstract][Full Text] [Related]
2. Livin regulates prostate cancer cell invasion by impacting the NF-κB signaling pathway and the expression of FN and CXCR4.
Chen F; Yang D; Wang S; Che X; Wang J; Li X; Zhang Z; Chen X; Song X
IUBMB Life; 2012 Mar; 64(3):274-83. PubMed ID: 22271494
[TBL] [Abstract][Full Text] [Related]
3. Elevation of SHARPIN Protein Levels in Prostate Adenocarcinomas Promotes Metastasis and Impairs Patient Survivals.
Huang H; Du T; Zhang Y; Lai Y; Li K; Fan X; Zhu D; Lin T; Xu K; Huang J; Liu L; Guo Z
Prostate; 2017 May; 77(7):718-728. PubMed ID: 28230260
[TBL] [Abstract][Full Text] [Related]
4. Livin mediates tumor cell invasion in the DU-145 cell line via NF-κB.
Chen F; Yang D; Che X; Wang J; Li X; Zhang Z; Chen X; Song X
Oncol Rep; 2012 Jun; 27(6):2010-6. PubMed ID: 22427141
[TBL] [Abstract][Full Text] [Related]
5. SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathway.
Li J; Lai Y; Cao Y; Du T; Zeng L; Wang G; Chen X; Chen J; Yu Y; Zhang S; Zhang Y; Huang H; Guo Z
Med Oncol; 2015 Feb; 32(2):444. PubMed ID: 25550157
[TBL] [Abstract][Full Text] [Related]
6. miR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB.
Du Y; Zhu M; Zhou X; Huang Z; Zhu J; Xu J; Cheng G; Shu Y; Liu P; Zhu W; Wang T
Tumour Biol; 2016 Jan; 37(1):1261-9. PubMed ID: 26286834
[TBL] [Abstract][Full Text] [Related]
7. SHARPIN overexpression promotes TAK1 expression and activates JNKs and NF-κB pathway in Mycosis Fungoides.
Chen B; Zheng Y; Zhu J; Liang Y
Exp Dermatol; 2019 Nov; 28(11):1279-1288. PubMed ID: 31461795
[TBL] [Abstract][Full Text] [Related]
8. Expression of Livin and the inhibition of tumor progression by Livin silencing in laryngohypopharyngeal cancer.
Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
In Vivo; 2014; 28(5):751-9. PubMed ID: 25189886
[TBL] [Abstract][Full Text] [Related]
9. DOK3 promotes proliferation and inhibits apoptosis of prostate cancer via the NF-κB signaling pathway.
Jin K; Qiu S; Chen B; Zhang Z; Zhang C; Zhou X; Yang L; Ai J; Wei Q
Chin Med J (Engl); 2023 Feb; 136(4):423-432. PubMed ID: 36867541
[TBL] [Abstract][Full Text] [Related]
10. Survivin mRNA-circulating tumor cells are associated with prostate cancer metastasis.
Wang H; Yang M; Xu J; Zou B; Zhou Q; Bian J; Wang X
Tumour Biol; 2016 Jan; 37(1):723-7. PubMed ID: 26242261
[TBL] [Abstract][Full Text] [Related]
11. Effects of monomethoxypolyethylene glycol-chitosan nanoparticle-mediated dual silencing of livin and survivin genes in prostate cancer PC-3M cells.
Yang AQ; Wang PJ; Huang T; Zhou WL; Landman J
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173182
[TBL] [Abstract][Full Text] [Related]
12. SHARPIN Promotes Melanoma Progression via Rap1 Signaling Pathway.
Zhou S; Liang Y; Zhang X; Liao L; Yang Y; Ouyang W; Xu H
J Invest Dermatol; 2020 Feb; 140(2):395-403.e6. PubMed ID: 31401046
[TBL] [Abstract][Full Text] [Related]
13. Effects of shRNA-silenced livin and survivin on lung cancer cell proliferation and apoptosis.
Zhao X; Yuan Y; Zhang Z; Feng X; Zhang J; Yuan X; Li J
J BUON; 2014; 19(3):757-62. PubMed ID: 25261663
[TBL] [Abstract][Full Text] [Related]
14. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
[TBL] [Abstract][Full Text] [Related]
15. NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo.
Cui X; Shen D; Kong C; Zhang Z; Zeng Y; Lin X; Liu X
Sci Rep; 2017 Jan; 7():40723. PubMed ID: 28139689
[TBL] [Abstract][Full Text] [Related]
16. Erratum: Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer.
Cancer; 2017 Mar; 123(5):892-893. PubMed ID: 28221687
[No Abstract] [Full Text] [Related]
17. High expression of DDX20 enhances the proliferation and metastatic potential of prostate cancer cells through the NF-κB pathway.
Chen W; Zhou P; Li X
Int J Mol Med; 2016 Jun; 37(6):1551-7. PubMed ID: 27121695
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor β suppresses inflammation and the progression of prostate cancer.
Xiao L; Luo Y; Tai R; Zhang N
Mol Med Rep; 2019 May; 19(5):3555-3563. PubMed ID: 30864712
[TBL] [Abstract][Full Text] [Related]
19. NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression.
McCall P; Bennett L; Ahmad I; Mackenzie LM; Forbes IW; Leung HY; Sansom OJ; Orange C; Seywright M; Underwood MA; Edwards J
Br J Cancer; 2012 Oct; 107(9):1554-63. PubMed ID: 23093296
[TBL] [Abstract][Full Text] [Related]
20. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
